The American Society for Pharmacology & Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS) and Wiley are pleased to announce that the Editor-in-Chief of Pharmacology Research & Perspectives from 1 January 2016 will be Professor Darrell Abernethy from Johns Hopkins Univ. School of Medicine, who has been Deputy Editor of the journal since 2013. The three partners jointly publish Pharmacology Research & Perspectives, which is a bi-monthly open access journal featuring a broad range of pharmacological research articles and several types of special articles on five key topics: target validation, drug discovery reviews, frontiers in translational medicine, pharmacological hypotheses, and replication studies.
“I am delighted that Professor Abernethy will be leading the continued development of Pharmacology Research & Perspectives,” explains Dr Mary Vore, chair of the ASPET Board of Publications Trustees. “All three organisations look forward to supporting his goals for the journal’s next phase: engaging pharmacologists worldwide and attracting more direct submissions in order to publish a greater number of good-quality manuscripts and, ultimately, meet the needs of the international pharmacology community.”
The appointment of Professor Andrew Lawrence of the Florey Institute of Neuroscience & Mental Health in Australia as the next Deputy Editor has also been revealed, with his term also beginning on 1 January 2016.
“Professor Lawrence’s appointment comes at an exciting time for Pharmacology Research & Perspectives,” comments Fiona Seymour, Senior Journals Open Access Editor at Wiley. “Our international reach is increasing at a significant rate and authors are responding well to our calls for special papers. His considerable knowledge of the global pharmacology research community, particularly in Australasia and Asia Pacific, will be valuable as we seek to build on the journal’s progress since its launch in 2013.”
The current Editor-in-Chief of Pharmacology Research & Perspectives is Dr Michael Curtis, who led the first 14 issues of the journal with support from its Deputy Editor and Editorial Board members. His term ends on 31 December 2015.
“On behalf of the three joint publishers, I want to offer many thanks to our current – and first – Editor-in-Chief Dr Michael Curtis for his commitment, hard work and vision during the launch and ongoing development of the journal. I have no doubt that he will continue to be a leading supporter of the journal in the coming years,” adds Professor Graeme Henderson, BPS Vice President – Publications.
About the incoming Editor-in-Chief
Dr Darrell Abernethy is Professor of Medicine and Pharmacology and Molecular Science (part-time), Johns Hopkins Univ. School of Medicine. He received his MD (AOA) and PhD (Pharmacology) degrees from the University of Kansas School of Medicine. He is an experienced editor having served as Editor-in-Chief of Pharmacological Reviews and as an Associate Editor of the Journal of Pharmacology & Experimental Therapeutics among other positions. He has contributed to the understanding of mechanisms of peripheral distribution of drugs and drug disposition and effect in obesity.
About the incoming Deputy Editor
As well as being a BPS Fellow, Professor Andrew Lawrence is head of the Behavioural Neuroscience Division at the Florey, overseeing 50 researchers. His primary research interest is in the development of robust animal models of drug-seeking, drug-taking and drug-induced neural adaptation. He has published over 150 original articles and has sat on a number of editorial boards, including his current role as Reviews Editor of The British Journal of Pharmacology. He is also the President of the Asian-Pacific Society for Neurochemistry.